The extent of HLA-DR expression on HLA-DR(+) Tregs allows the identification of patients with clinically relevant borderline rejection.
about
Cell therapy for immunosuppression after kidney transplantation.Cell therapeutic approaches to immunosuppression after clinical kidney transplantation.Comprehensive phenotyping of regulatory T cells after liver transplantation.Acute Rejection Phenotypes in the Current Era of Immunosuppression: A Single-Center Analysis.The role of regulatory T cell (Treg) subsets in gestational diabetes mellitus.
P2860
The extent of HLA-DR expression on HLA-DR(+) Tregs allows the identification of patients with clinically relevant borderline rejection.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
The extent of HLA-DR expression on HLA-DR
@nl
The extent of HLA-DR expressio ...... relevant borderline rejection.
@en
type
label
The extent of HLA-DR expression on HLA-DR
@nl
The extent of HLA-DR expressio ...... relevant borderline rejection.
@en
prefLabel
The extent of HLA-DR expression on HLA-DR
@nl
The extent of HLA-DR expressio ...... relevant borderline rejection.
@en
P2093
P2860
P356
P1476
The extent of HLA-DR expressio ...... relevant borderline rejection.
@en
P2093
Andrea Steinborn
Claudia Sommerer
Edgar Schmitt
Friederike Hug
Luis Eduardo Becker
Martin Zeier
Nicole Seissler
Rüdiger Waldherr
Sebastian Markus Schaefer
Stefan Meuer
P2860
P304
P356
10.1111/TRI.12032
P577
2013-01-02T00:00:00Z